EyePoint Pharmaceuticals (EYPT) Misses Q1 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Citi Opens 30-Day Upside Catalyst Watch on EyePoint Inc. (EYPT)
May 6, 2026 4:08 PM EDTCiti analyst Yigal Nochomovitz reiterated a Buy rating and $35.00 price target on EyePoint Inc. (NASDAQ: EYPT)
Opens 30-Day upside catalyst watch.For an analyst ratings summary and ratings history on EyePoint Inc. click here. For more ratings news on EyePoint Inc. click here.
Shares of EyePoint Inc. closed at $13.75 yesterday.
... More